Autolus Therapeutics plc

AUTL · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.4B · 752 employees
118
SEC Filings
$1.7
Close 2026-07-08
752
Employees

Business Summary

PART I Business Overview We are an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation T cell therapies and candidates for the treatment of cancer and autoimmune diseases. Using our broad suite of proprietary and modular T cell programming technologies, we are engineering precisely targeted and controlled T cell therapies that are designed to better recognize target cells, break down their defense mechanisms and eliminate target cells. We bel...

Latest Stock Quote

AUTL 2026-07-08 $1.7 O:$1.6 H:$1.745 L:$1.6 Vol:1.7M VWAP:$1.6877
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-15

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-272025-12-310001730463-26-000038EDGAR145K words
2025-03-202024-12-310001730463-25-000019EDGAR—
2024-03-212023-12-310001730463-24-000048EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001730463-25-000088EDGAR33K words
2025-08-122025-06-300001730463-25-000067EDGAR—
2025-05-082025-03-310001730463-25-000039EDGAR—
2024-11-122024-09-300001730463-24-000136EDGAR—
2024-08-082024-06-300001730463-24-000093EDGAR—
2024-05-172024-03-310001730463-24-000064EDGAR—
2023-11-092023-09-300001730463-23-000110EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-030001730463-26-000112EDGAR—
2026-08-030001193125-26-329526EDGAR—
2026-03-270001730463-26-000032EDGAR1K words
2026-01-260001730463-26-000019EDGAR—
2026-01-120001730463-26-000012EDGAR—
2025-12-020001730463-25-000095EDGAR—
2025-11-120001730463-25-000081EDGAR—
2025-08-120001730463-25-000064EDGAR—
2025-06-270001730463-25-000046EDGAR—
2025-06-020001730463-25-000043EDGAR—

118 total filings indexed. 98 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Company Identity

CIK0001730463
TickerAUTL
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedX0
Websitehttps://www.autolus.com
Listed2018-06-22

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: bd162a9f849c929d0aaf178186d2e5c3cab02c4c9053c00dd14b45abd33714cd
parent: 51f10ac5653059352dabc58a33105113b9975fcac765183cca4959610372e449
content hash: 8355bd1a91214612ca9009915de8e72c87c0088e8fc68463738fdf100ad43693
signed: 2026-08-10T19:01:03.244Z
sources: 10 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up AUTL using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on AUTL, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/AUTL (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.